These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2939433

  • 1. [Osteocalcin (or bone gla-protein), a new biological marker for studying bone pathology].
    Delmas PD, Demiaux B, Malaval L, Chapuy MC, Meunier PJ.
    Presse Med; 1986 Apr 05; 15(14):643-6. PubMed ID: 2939433
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.
    Coen G, Ballanti P, Balducci A, Grandi F, Manni M, Mantella D, Pierantozzi A, Ruggeri M, Sardella D, Sorbo G, Bonucci E.
    Am J Kidney Dis; 2006 Jul 05; 48(1):106-13. PubMed ID: 16797392
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein.
    Delmas PD, Wahner HW, Mann KG, Riggs BL.
    J Lab Clin Med; 1983 Oct 05; 102(4):470-6. PubMed ID: 6604769
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of serum osteocalcin as an index of altered bone metabolism.
    Kruse K, Kracht U.
    Eur J Pediatr; 1986 Apr 05; 145(1-2):27-33. PubMed ID: 3015628
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Osteocalcin in chronic hemodialysis patients as an additional parameter in the diagnosis of advanced secondary hyperparathyroidism].
    Motz W.
    Acta Med Austriaca; 1989 Apr 05; 16(1):8-12. PubMed ID: 2785325
    [Abstract] [Full Text] [Related]

  • 15. [Bone Gla-protein (osteocalcin): a new metabolic marker of calcified tissues].
    Fiore CE, Malatino LS, Tamburino G.
    Recenti Prog Med; 1984 Apr 05; 75(4):361-81. PubMed ID: 6374796
    [No Abstract] [Full Text] [Related]

  • 16. Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis.
    Torres R, de la Piedra C, Rapado A.
    Scand J Clin Lab Invest; 1989 May 05; 49(3):279-85. PubMed ID: 2787049
    [Abstract] [Full Text] [Related]

  • 17. Serum osteocalcin levels in normal subjects and patients with primary hyperparathyroidism.
    Ljunghall S, Hällgren R, Rastad J.
    Exp Clin Endocrinol; 1985 Dec 05; 86(2):218-22. PubMed ID: 3879222
    [Abstract] [Full Text] [Related]

  • 18. Urinary gamma-carboxyglutamic acid and serum osteocalcin as bone markers: studies in osteoporosis and Paget's disease.
    Gundberg CM, Lian JB, Gallop PM, Steinberg JJ.
    J Clin Endocrinol Metab; 1983 Dec 05; 57(6):1221-5. PubMed ID: 6605357
    [Abstract] [Full Text] [Related]

  • 19. Effect of acute increases in bone matrix degradation on circulating levels of bone-Gla protein.
    Riggs BL, Tsai KS, Mann KG.
    J Bone Miner Res; 1986 Dec 05; 1(6):539-42. PubMed ID: 3509744
    [Abstract] [Full Text] [Related]

  • 20. Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease.
    Duda RJ, O'Brien JF, Katzmann JA, Peterson JM, Mann KG, Riggs BL.
    J Clin Endocrinol Metab; 1988 May 05; 66(5):951-7. PubMed ID: 3258870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.